European Psychiatry: Volume 15 - Congress of the Association of European Psychiatrists

European Psychiatry

Only show content I have access to (976)

Over 3 years (976)

View selected items
Save to my bookmarks
Export citations
Download PDF (zip)
Save to Kindle
Save to Dropbox
Save to Google Drive
Save content to
To save this undefined to your undefined account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you used this feature, you will be asked to authorise Cambridge Core to connect with your undefined account. Find out more about saving content to .

To save this article to your Kindle, first ensure [email protected] is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Please be advised that item(s) you selected are not available.
You are about to save
European Psychiatry
ISSN: 0924-9338

EISSN: 1778-3585

URL: /core/journals/european-psychiatry
Your Kindle email address

Please provide your Kindle email.

@free.kindle.com @kindle.com (service fees apply)

By using this service, you agree that you will only keep content for personal use, and will not openly distribute them via Dropbox, Google Drive or other file sharing services

European Psychiatry

Refine listing

Actions for selected content:

Congress of the Association of European Psychiatrists

Posters, Sunday, 29 October 2000

Symposia

P01.12 Ethic decisions on involuntary treatment of patients with schizophrenia

P01.13 Clinical and eeg predictors of the therapepeutic outcome of electroconvulsive therapy

P01.15 Neurocognitive changes in adjustment disorder with depressed mood: Use of paroxetine

P01.14 Olanzapine: Effects on neuropsychological test performances in the schizophrenic spectrum

P01.16 Gabapentin in antipsychotic-induced movements

P01.17 Adjunctive amisulpride to fluvoxamine in major depression: Early ssri onset of action

P01.18 Role of pro-inflammatory cytokines in down's syndrome

P01.19 Lack of effects of st john’s wort extract on autonomic and cognitive functions

P01.20 Comparison of effects of panic disorder with agoraphobia in men and women

P01.22 Predictors of chronicity and health service use in patients presenting unexplained physical symptoms

P01.23 Compliance inventory (CI-6)

P01.21 Augmantation with d2 antagonists for partial reponders to atypical antipsychotics

P01.24 Proximity to the community or specialisation of psychiatric in-patient care (part 1)

P01.25 The motivations for opiate use among addicts of shiraz self-identified center

P01.26 The effect of cultural factors on students' drug use

P01.27 A comparison of two different instruments assessing the individual need for care

P01.28 Effects of new antipsychotics on serum prolactin and testosterone level in schizophrenic patients

P01.30 Altered biochemical bone remodelling markers in schizophrenia

P01.29 Psychiatry in intelectual disability: The “tools of care” in Geneva

P01.31 Functional relationship between enzymes MAOA and ace in human brain?

European Psychiatry

Refine listing

Actions for selected content:

Save Search

Congress of the Association of European Psychiatrists

Posters, Sunday, 29 October 2000

Symposia